{"id":"W3092361090","doi":"10.1111/dom.14223","title":"Design and baseline characteristics of the <scp>AMPLITUDE‐O</scp> cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Internal medicine; Placebo; Adverse effect; Diabetes mellitus; Renal function; Glucagon-like peptide 1 receptor; Stroke (engine); Myocardial infarction; Type 2 diabetes; Kidney disease; Agonist; Endocrinology; Receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003658725,0.002018007,0.002467211,0.0003336978,0.000804637,0.001318056,0.0006309641,0.001691764,0.009315798],"category_scores_gemma":[0.0028763,0.0008780399,0.001544297,0.0005139509,0.001019165,0.001066029,0.0005721524,0.002126149,0.001410949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007249024,"about_ca_system_score_gemma":0.001402608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009101731,"about_ca_topic_score_gemma":0.001711044,"domain_scores_codex":[0.9978357,0.0009553516,0.000176106,0.0004398531,0.0001756712,0.0004174225],"domain_scores_gemma":[0.9988922,0.0001630402,0.0002168985,0.00008573654,0.00008394229,0.0005581919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9698904,0.008215365,0.008918812,0.0003332164,0.0009495714,0.00009120908,0.00007842053,0.0002578419,0.002069627,0.0002768919,0.001186313,0.00773231],"study_design_scores_gemma":[0.8337817,0.1287743,0.03004893,0.0001115291,0.00145017,0.0001307223,0.00009157928,0.0007047949,0.0004663302,0.001084974,0.003288086,0.00006678374],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.9569831,0.003455098,0.001401323,0.00127799,0.0006472644,0.02452433,0.004667939,0.00005545844,0.006987506],"genre_scores_gemma":[0.9490115,0.001095137,0.002269321,0.002593813,0.0006250171,0.03561542,0.002835719,0.00002284944,0.005931118],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.009315798,"threshold_uncertainty_score":0.03116441,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01793054011028328,"score_gpt":0.2195581225120175,"score_spread":0.2016275824017342,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}